Tu1470: RISANKIZUMAB MAINTENANCE THERAPY RESULTS IN SUSTAINED IMPROVEMENTS IN ENDOSCOPIC OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: POST-HOC ANALYSIS FROM THE PHASE 3 STUDY FORTIFY

Gastroenterology(2022)

引用 0|浏览2
暂无评分
关键词
risankizumab maintenance therapy,severe crohns,endoscopic outcomes,post-hoc
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要